Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 234 results

Search term: MF = 'C_{26}H_{30}ClFN_{2}O_{2}'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
10482030

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H29FN2O2.ClH/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20;/h2-10,19,23H,11-17H2,1H3,(H,30,31);1H/t19-,23-,25-,26-;/m1./s1
C26H30ClFN2O2456.98333730
173932
InChI=1/C26H30ClFN2O2/c27-22-6-3-5-21(19-22)26(25(32)30-15-1-2-16-30)12-17-29(18-13-26)14-4-7-24(31)20-8-10-23(28)11-9-20/h3,5-6,8-11,19H,1-2,4,7,12-18H2
C26H30ClFN2O2456.98171800
49122

2 of 4 defined stereocentres - 2/4 defined
InChI=1/C26H29FN2O2.ClH/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20;/h2-10,19,23H,11-17H2,1H3,(H,30,31);1H/t19-,23?,25?,26-;/m1./s1
C26H30ClFN2O2456.9800032151000
25048148

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H29FN2O2.ClH/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20;/h2-10,19,23H,11-17H2,1H3,(H,30,31);1H/t19-,23-,25-,26-;/m0./s1
C26H30ClFN2O2456.98151500
2517874

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C26H30ClFN2O2/c1-2-3-4-17-5-7-19(8-6-17)26(32)30-16-24(31)29-23-14-11-20(27)15-22(23)25(30)18-9-12-21(28)13-10-18/h9-15,17,19,25H,2-8,16H2,1H3,(H,29,31)
C26H30ClFN2O2456.98121000
392061

0 of 4 defined stereocentres - 0/4 defined
InChI=1/C26H29FN2O2.ClH/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20;/h2-10,19,23H,11-17H2,1H3,(H,30,31);1H
C26H30ClFN2O2456.980003282700
24580869

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H29FN2O2.ClH/c1-3-16-15-29-11-10-17(16)12-25(29)26(30)21-14-24(19-6-4-5-7-22(19)27)28-23-9-8-18(31-2)13-20(21)23;/h4-9,13-14,16-17,25-26,30H,3,10-12,15H2,1-2H3;1H/t16-,17-,25-,26+;/m0./s1
C26H30ClFN2O2456.984400
24580870

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H29FN2O2.ClH/c1-3-16-15-29-10-9-17(16)12-25(29)26(30)22-14-24(18-5-4-6-19(27)11-18)28-23-8-7-20(31-2)13-21(22)23;/h4-8,11,13-14,16-17,25-26,30H,3,9-10,12,15H2,1-2H3;1H/t16-,17-,25-,26+;/m0./s1
C26H30ClFN2O2456.984400
24580871

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H29FN2O2.ClH/c1-3-16-15-29-11-10-18(16)12-25(29)26(30)22-14-24(17-4-6-19(27)7-5-17)28-23-9-8-20(31-2)13-21(22)23;/h4-9,13-14,16,18,25-26,30H,3,10-12,15H2,1-2H3;1H/t16-,18-,25-,26+;/m0./s1
C26H30ClFN2O2456.984400
24581046

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C26H29FN2O2.ClH/c1-3-16-15-29-11-10-18(16)12-25(29)26(30)22-14-24(17-4-6-19(27)7-5-17)28-23-9-8-20(31-2)13-21(22)23;/h4-9,13-14,16,18,25-26,30H,3,10-12,15H2,1-2H3;1H/t16-,18+,25+,26-;/m0./s1
C26H30ClFN2O2456.984400
9457506

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C26H30ClFN2O2/c27-20-5-3-4-19(16-20)26(32)11-2-1-6-23(26)30-14-12-25(13-15-30)22(17-29-24(25)31)18-7-9-21(28)10-8-18/h3-5,7-10,16,22-23,32H,1-2,6,11-15,17H2,(H,29,31)
C26H30ClFN2O2456.984300
15869

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClFN2O2/c27-22-10-6-9-21(19-22)26(25(32)30-15-4-5-16-30)13-17-29(18-14-26)24(28)12-11-23(31)20-7-2-1-3-8-20/h1-3,6-10,19,24H,4-5,11-18H2
C26H30ClFN2O2456.983200
3197581
InChI=1/C26H30ClFN2O2/c1-2-3-4-5-15-29-26(31)25-14-13-24(32-25)19-30(17-20-9-11-22(27)12-10-20)18-21-7-6-8-23(28)16-21/h6-14,16H,2-5,15,17-19H2,1H3,(H,29,31)
C26H30ClFN2O2456.982100
13132082

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClFN2O2/c27-23-11-6-5-8-19(23)18-30-24(31)12-7-17-26(30,20-13-15-21(28)16-14-20)25(32)29-22-9-3-1-2-4-10-22/h5-6,8,11,13-16,22H,1-4,7,9-10,12,17-18H2,(H,29,32)
C26H30ClFN2O2456.982200
64884985

2 of 4 defined stereocentres - 2/4 defined
InChI=1/C26H29FN2O2.ClH/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20;/h2-10,19,23H,11-17H2,1H3,(H,30,31);1H/t19?,23-,25-,26?;
C26H30ClFN2O2456.982200
78297897
InChI=1/C26H30ClFN2O2/c1-18-7-8-19(15-23(18)28)17-29-24(31)20-9-13-30(14-10-20)25(32)26(11-2-3-12-26)21-5-4-6-22(27)16-21/h4-8,15-16,20H,2-3,9-14,17H2,1H3,(H,29,31)
C26H30ClFN2O2456.982200
90655868

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H29FN2O2.ClH/c27-23-10-6-21(7-11-23)18-22-8-12-24(13-9-22)29-16-14-28(15-17-29)19-25(30)20-31-26-4-2-1-3-5-26;/h1-13,25,30H,14-20H2;1H
C26H30ClFN2O2456.982200
112315508

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C26H30ClFN2O2/c1-25(2,3)18-10-12-26(13-11-18,30-16-17-6-4-5-7-20(17)24(30)32)15-23(31)29-19-8-9-22(28)21(27)14-19/h4-9,14,18H,10-13,15-16H2,1-3H3,(H,29,31)
C26H30ClFN2O2456.981100
112384033

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C26H30ClFN2O2/c1-2-3-4-18-5-10-20(11-6-18)26(32)29-22-14-15-23(27)24(17-22)30-25(31)16-9-19-7-12-21(28)13-8-19/h7-9,12-18,20H,2-6,10-11H2,1H3,(H,29,32)(H,30,31)/b16-9+
C26H30ClFN2O2456.981100
112451203

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C26H30ClFN2O2/c1-2-3-5-18-8-11-20(12-9-18)26(32)30-24-17-22(13-14-23(24)27)29-25(31)15-10-19-6-4-7-21(28)16-19/h4,6-7,10,13-18,20H,2-3,5,8-9,11-12H2,1H3,(H,29,31)(H,30,32)/b15-10+
C26H30ClFN2O2456.981100
12345

Advertisement